(S)-1-((3S,6S,9R,12S,15R,18S,21S)-3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide 2,2,2-Trifluoroacetate; (D-Ser4)-Leuprolide ; 4-D-Serine-6-D-leucine-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing hormone-releasing Factor (pig); D-Ser-Leuprolide.
Leuprolide (Leuprorelin) EP Impurity A (TFA Salt) is a fully characterized chemical compound used as a reference standard of API Leuprolide. The standard offered is compliant with regulatory guidelines. Leuprolide (Leuprorelin) EP Impurity A (TFA Salt) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Leuprorelin EP Impurity G (Leuprolide EP Impurity G)
M.F.
M.W. 1209.42
CAT# AR-L01442
CAS# 112710-57-3
